Genesis Emerging Markets Fund (GSS) Share Price, News & Analysis

Company Overview

Genesis Emerging Markets Fund is a closed ended equity mutual fund launched by Genesis Asset Managers, LLP. The fund is managed by Genesis Investment Management, LLP. It invests in the public equity markets of emerging countries across the globe. The fund invests in stocks of companies operating across diversified sectors. It invests in value stocks of companies. The fund employs fundamental analysis with bottom-up stock picking approach focusing on factors such as emerging market growth opportunities and companies which are found to be trading at an attractive discount to their assessed intrinsic value, Structural Changes, Change at the Corporate Level and Stock market Inefficiencies to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI World Total Return Index and MSCI EM (TR) Index. The fund conducts in-house research to make its investments. Genesis Emerging Markets Fund was formed in June 7, 1989 and is domiciled in Guernsey, Channel Islands.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 27,013 shs
• Average Volume: 78,356 shs
• Market Capitalization: £1.06 billion
• P/E Ratio: 6.18
• Dividend Yield: 1.47%
• Price Target: N/A
• Consensus Rating: N/A

GSS Stock Analysis - Frequently Asked Questions

How do I buy shares of Genesis Emerging Markets Fund?

Shares of GSS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Genesis Emerging Markets Fund own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Emerging Markets Fund investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Finance
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:GSS
• CIK: N/A
• Web: www.giml.co.uk
• Phone: 1442081677000
• Fax: N/A
• Employees: 1,626
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 6.18
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 197.11
• Quick Ratio: 197.11

Sales & Book Value

• Annual Sales: £250.40 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.67
• Book Value: GBX 1,322.60 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 121,467,000
• Free Float: N/A
• Market Cap: £1.06 billion
• Optionable: Not Optionable
• Beta: N/A